Kern Pharma
Kern Pharma, a prominent player in the pharmaceutical industry, is headquartered in Spain (ES) and operates extensively across Europe and Latin America. Founded in 2000, the company has established itself as a leader in the development, manufacturing, and marketing of generic and specialty pharmaceuticals. Kern Pharma's core offerings include a diverse range of high-quality medicines, particularly in the fields of oncology, cardiology, and central nervous system disorders. Their commitment to innovation and quality sets them apart in a competitive market. With a strong focus on research and development, Kern Pharma has achieved significant milestones, positioning itself as a trusted partner in healthcare. The company’s dedication to improving patient outcomes and expanding access to essential medications underscores its notable achievements in the pharmaceutical landscape.
DitchCarbon Score
How does Kern Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kern Pharma's score of 3 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kern Pharma's reported carbon emissions
Kern Pharma, headquartered in Spain (ES), currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. While there are no documented reduction targets or climate pledges from Kern Pharma, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon emissions. Companies in this sector are often encouraged to adopt science-based targets and engage in initiatives aimed at minimising their environmental impact. Kern Pharma's commitment to addressing climate change may align with broader industry trends, but without specific data or targets, their current stance on carbon emissions remains unclear.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kern Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
